DYNAGLIPT-M TABLET

Dynaglipt-M Tablet belongs to the group of medications called ‘antidiabetic agents’ used to treat Type 2 diabetes mellitus. This medication improves glycaemic control in diabetic patients who do not react well to Metformin alone.  Type 2 diabetes mellitus is a chronic or life-long condition in which blood sugar or glucose levels rise more than normal. It occurs when the body does not produce enough insulin (metabolizes glucose), or if produced, it cannot function properly in the body.

Dynaglipt-M Tablet is a combination of two medicines, namely: Metformin and Teneligliptin. Metformin comes into the category of medications known as ‘biguanides’, and it acts by decreasing liver glucose production and intestinal glucose uptake. On the other side, Teneligliptin works by stopping the action of the dipeptidyl Peptidase 4 enzyme, which in turn increases the insulin levels in the body and reduces the glucagon levels. All of these actions reduce sugar levels in the body.

You should take this medicine as prescribed by your doctor. You may experience side-effects of such as nausea (feeling sick), vomiting (falling sick), diarrhoea, headache, stomach ache, respiratory infection, weight gain, sweating, palpitations, and vision problems. Some patients experience decline in blood sugar levels lower than normal (hypoglycemia), resulting in sweating, dizziness, headache, confusion, feeling hungry, temporary changes in vision, uneasiness, irritability, and weakness. In such cases, seek medical attention immediately.

Do not take Dynaglipt-M Tablet if you are allergic to any of its contents. Do not use this medicine if you have heart failure, bladder cancer, or diabetic ketoacidosis (a complication of diabetes). Dynaglipt-M Tablet may cause ‘lactic acidosis’ (accumulation of lactic acid in the blood), which requires immediate medical attention. The risk increases if you are previously diagnosed with kidney or liver diseases. Do not consume alcohol (risk of lactic acidosis) or fast for prolonged periods (risk of hypoglycemia). Also, inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.

Treatment of Type 2 Diabetes Mellitus.

Dynaglipt-M Tablet is suggested for the management of type 2 diabetes to be followed with the right diet and exercise. Dynaglipt-M Tablet is given in combination in patients whose diabetes is not effectively controlled with Metformin alone.  This medicine makes the body more responsive to insulin and helps the body to a normal state.  Metformin tablets are especially advised to release the drug at a slow rate in the body from time to time.

Swallow it as a whole with water; do not crush, break or chew it.

Store in a cool and dry place away from sunlight

• Nausea (feeling sick)

• Vomiting (falling sick)

• Diarrhea

• Headache

• Stomach ache

• Respiratory infection

• Weight gain

• Sweating

• Palpitations

• Numbness

• Vision problems